Repositorio Dspace

Dexamethasone and Doxycycline Doped Nanoparticles Increase the Differentiation Potential of Human Bone Marrow Stem Cells

Mostrar el registro sencillo del ítem

dc.contributor.author Toledano-Osorio, Manuel
dc.contributor.author López-García, Sergio
dc.contributor.author Osorio, Raquel
dc.contributor.author Toledano, Manuel
dc.contributor.author García-Bernal, David
dc.contributor.author Sánchez-Bautista, Sonia
dc.contributor.author Rodríguez-Lozano, Francisco-Javier
dc.date.accessioned 2025-11-26T11:36:24Z
dc.date.available 2025-11-26T11:36:24Z
dc.date.issued 2022-09
dc.identifier.citation Toledano-Osorio M, López-García S, Osorio R, Toledano M, García-Bernal D, Sánchez-Bautista S, et al. Dexamethasone and Doxycycline Doped Nanoparticles Increase the Differentiation Potential of Human Bone Marrow Stem Cells. Pharmaceutics. 4 de septiembre de 2022;14(9):1865.
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/22580
dc.description.abstract Non-resorbable polymeric nanoparticles (NPs) are proposed as an adjunctive treatment for bone regenerative strategies. The present in vitro investigation aimed to evaluate the effect of the different prototypes of bioactive NPs loaded with zinc (Zn-NPs), doxycycline (Dox-NPs) or dexamethasone (Dex-NPs) on the viability, morphology, migration, adhesion, osteoblastic differentiation, and mineralization potential of human bone marrow stem cells (hBMMSCs). Cell viability, proliferation, and differentiation were assessed using a resaruzin-based assay, cell cycle analysis, cell migration evaluation, cell cytoskeleton staining analysis, Alizarin Red S staining, and expression of the osteogenic-related genes by a real-time quantitative polymerase chain reaction (RT-qPCR). One-Way ANOVA and Tukey's test were employed. The resazurin assay showed adequate cell viability considering all concentrations and types of NPs at 24, 48, and 72 h of culture. The cell cycle analysis revealed a regular cell cycle profile at 0.1, 1, and 10 µg/mL, whereas 100 µg/mL produced an arrest of cells in the S phase. Cells cultured with 0.1 and 1 µg/mL NP concentrations showed a similar migration capacity to the untreated group. After 21 days, mineralization was increased by all the NPs prototypes. Dox-NPs and Dex-NPs produced a generalized up-regulation of the osteogenic-related genes. Dex-NPs and Dox-NPs exhibited excellent osteogenic potential and promoted hBMMSC differentiation. Future investigations, both in vitro and in vivo, are required to confirm the suitability of these NPs for their clinical application.
dc.language.iso eng
dc.publisher MDPI
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0 *
dc.title Dexamethasone and Doxycycline Doped Nanoparticles Increase the Differentiation Potential of Human Bone Marrow Stem Cells
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 36145613
dc.relation.publisherversion https://www.mdpi.com/1999-4923/14/9/1865
dc.identifier.doi 10.3390/pharmaceutics14091865
dc.journal.title Pharmaceutics
dc.identifier.essn 1999-4923


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta